We are live on ! Find out more
OAM

Oberweis Asset Management Portfolio holdings

AUM $3.39B
1-Year Est. Return 105.5%
This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+105.5%
3 Year Est. Return
+311.52%
5 Year Est. Return
+632.9%
10 Year Est. Return
+11,604.3%
AUM
$550M
AUM Growth
+$52.4M
Cap. Flow
+$19.4M
Cap. Flow %
3.53%
Top 10 Hldgs %
52.39%
Holding
230
New
29
Increased
85
Reduced
59
Closed
34

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$47.5M
2
QURE icon
uniQure
QURE
+$28.2M
3
CACI icon
CACI
CACI
+$6.46M
4
IPHI
INPHI CORPORATION
IPHI
+$4.67M
5
ALTR
Altair Engineering Inc
ALTR
+$4.62M

Top Sells

Rank Stock Value
1
MLNX
Mellanox Technologies, Ltd.
MLNX
+$33.8M
2
GOOS
Canada Goose Holdings
GOOS
+$13.2M
3
BEAT
BioTelemetry, Inc.
BEAT
+$8.78M
4
CYBR
CyberArk
CYBR
+$5.02M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$4.83M

Sector Composition

Rank Sector Weight
1 Healthcare 39.64%
2 Consumer Staples 13.57%
3 Technology 13.22%
4 Industrials 12.46%
5 Consumer Discretionary 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEAT
226
DELISTED
BioTelemetry, Inc.
BEAT
– –
-140,180
Closed -$8.78M
6 7 8 9
10

Similar funds

BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

Oberweis Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Oberweis Asset Management held 230 positions worth $550M, up 11% from $498M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Oberweis Asset Management deployed $19.4M of net new capital in Q2 2019, opening 29 new positions and adding to 85 existing holdings. Its largest new stake was uniQure: 442,900 shares worth $34.6M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 28% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Ligand Pharmaceuticals, an estimated $4.83M trimmed.

  • Oberweis Asset Management's largest Q2 2019 buy was uniQure: 442,900 shares worth $34.6M.
  • Oberweis Asset Management added most to GW Pharmaceuticals Plc American Depositary Shares in Q2 2019, an estimated $47.5M increase.
  • Oberweis Asset Management's biggest Q2 2019 reduction was Ligand Pharmaceuticals, cutting an estimated $4.83M.
  • Oberweis Asset Management fully exited Mellanox Technologies, Ltd. in Q2 2019, selling an estimated $33.8M.
  • Oberweis Asset Management's ten largest holdings make up 52% of its $550M portfolio in Q2 2019.
  • Oberweis Asset Management opened 29 new positions and closed 34 in Q2 2019.
  • Oberweis Asset Management's portfolio value rose 11% quarter-over-quarter to $550M.

Based on Oberweis Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.